Record 041 · Therapeutics · 2012
50%12.41.X
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals
“Selective mTORC1 inhibitors — rapamycin’s smarter cousin.”
Aeovian (ex-Aeonian) builds mTORC1-selective drugs so you can get the longevity pathway without the rapamycin baggage.
The rapamycin thesis, medicalized.
Series A. Filed from the Top Tier Impact landscape.
- Selective mTORC1
- Neurology + aging
mTOR, aimed.
